OBJECTIVE: To analyse intraoperative costs and healthcare reimbursements of partial/radical nephrectomy in open and minimal invasive surgery (MIS), as laparoscopy and laparoendoscopic single-site surgery (LESS), for the treatment of renal tumour. MATERIALS AND METHODS: In a non-randomized retrospective study, we selected 90 patients who underwent (01/2010-12/2011) partial and radical nephrectomy for clinical renal masses ≤7 cm (cT1N0M0) and divided them into laparoscopic [laparoscopic partial nephrectomy (LPN), laparoscopic radical nephrectomy (LRN)], LESS [laparoendoscopic single-site partial nephrectomy (LESS-PN), laparoendoscopic single-site radical nephrectomy (LESS-RN)] and open groups [open partial nephrectomy (OPN), open radical nephrectomy (ORN)]. Patients were matched for age, sex, body mass index, ASA score and tumour side. Primary endpoints were evaluation of intraoperative costs (general, laparoscopic, sutures, haemostatic agents, anaesthesia, and surgeon/nurses fee), total insurance and estimated daily reimbursement. RESULTS: MIS showed longer operative time (p ≤ .02) and shorter hospital stay (p ≤ .04). Total costs were higher (p ≤ .03) in MIS (LRN: 4,091.5 <euro>; LPN: 4,390.4 <euro>; LESS-RN: 3,866 <euro>; and LESS-PN: 3,450 <euro>) if compared with open (OPN: 2,216.8.8 <euro>, ORN: 1,606.4 <euro>). Laparoscopic materials incised mainly in total costs of MIS (38-58.1 %). Reusable instruments reduced LESS laparoscopic costs (LESS-PN: 1,312.2 <euro> vs. LRN: 2,212.2 <euro>, p < .0001). Intraoperative frozen section and DJ ureteric stenting (general costs) (p ≤ .008) and haemostatic agents use (p ≤ .01) were higher in nephron sparing surgery (NSS), due to more frequent use of ancillary procedures necessary for a safe management of such an approach. Estimated anaesthesia costs and doctor/nurses fee were higher in MIS (p ≤ .02). Whereas total final reimbursements were comparable (p ≥ .8), estimated daily reimbursements were lower in MIS (p < .001) due to higher intraoperative costs and longer operative time. CONCLUSION: Well-known advantages offered by MIS/NSS face higher total intraoperative costs and 'paradoxical' reduced healthcare reimbursement. We believe that local health systems should consider a subclassification with different compensations, which will incentive NSS and MIS approaches.
OBJECTIVE: To analyse intraoperative costs and healthcare reimbursements of partial/radical nephrectomy in open and minimal invasive surgery (MIS), as laparoscopy and laparoendoscopic single-site surgery (LESS), for the treatment of renal tumour. MATERIALS AND METHODS: In a non-randomized retrospective study, we selected 90 patients who underwent (01/2010-12/2011) partial and radical nephrectomy for clinical renal masses ≤7 cm (cT1N0M0) and divided them into laparoscopic [laparoscopic partial nephrectomy (LPN), laparoscopic radical nephrectomy (LRN)], LESS [laparoendoscopic single-site partial nephrectomy (LESS-PN), laparoendoscopic single-site radical nephrectomy (LESS-RN)] and open groups [open partial nephrectomy (OPN), open radical nephrectomy (ORN)]. Patients were matched for age, sex, body mass index, ASA score and tumour side. Primary endpoints were evaluation of intraoperative costs (general, laparoscopic, sutures, haemostatic agents, anaesthesia, and surgeon/nurses fee), total insurance and estimated daily reimbursement. RESULTS: MIS showed longer operative time (p ≤ .02) and shorter hospital stay (p ≤ .04). Total costs were higher (p ≤ .03) in MIS (LRN: 4,091.5 <euro>; LPN: 4,390.4 <euro>; LESS-RN: 3,866 <euro>; and LESS-PN: 3,450 <euro>) if compared with open (OPN: 2,216.8.8 <euro>, ORN: 1,606.4 <euro>). Laparoscopic materials incised mainly in total costs of MIS (38-58.1 %). Reusable instruments reduced LESS laparoscopic costs (LESS-PN: 1,312.2 <euro> vs. LRN: 2,212.2 <euro>, p < .0001). Intraoperative frozen section and DJ ureteric stenting (general costs) (p ≤ .008) and haemostatic agents use (p ≤ .01) were higher in nephron sparing surgery (NSS), due to more frequent use of ancillary procedures necessary for a safe management of such an approach. Estimated anaesthesia costs and doctor/nurses fee were higher in MIS (p ≤ .02). Whereas total final reimbursements were comparable (p ≥ .8), estimated daily reimbursements were lower in MIS (p < .001) due to higher intraoperative costs and longer operative time. CONCLUSION: Well-known advantages offered by MIS/NSS face higher total intraoperative costs and 'paradoxical' reduced healthcare reimbursement. We believe that local health systems should consider a subclassification with different compensations, which will incentive NSS and MIS approaches.
Authors: Hendrik Van Poppel; Luigi Da Pozzo; Walter Albrecht; Vsevolod Matveev; Aldo Bono; Andrzej Borkowski; Jean-Marie Marechal; Laurence Klotz; Eila Skinner; Thomas Keane; Ilse Claessens; Richard Sylvester Journal: Eur Urol Date: 2006-11-15 Impact factor: 20.096
Authors: Riccardo Autorino; Jihad H Kaouk; Rachid Yakoubi; Koon Ho Rha; Robert J Stein; Wesley M White; Jens-Uwe Stolzenburg; Luca Cindolo; Evangelos Liatsikos; Soroush Rais-Bahrami; Alessandro Volpe; Deok Hyun Han; Ithaar H Derweesh; Seung Wook Lee; Aly M Abdel-Karim; Anibal Branco; Francesco Greco; Mohamad Allaf; Rene Sotelo; Panagiotis Kallidonis; Byong Chang Jeong; Sara Best; Wassim Bazzi; Phillip Pierorazio; Salah Elsalmy; Abhay Rane; Woong Kyu Han; Bo Yang; Luigi Schips; Wilson R Molina; Paolo Fornara; Carlo Terrone; Camilo Giedelman; Joo Yong Lee; Sebastien Crouzet; Georges-Pascal Haber; Lee Richstone; Sun Yinghao; Fernando J Kim; Jeffrey A Cadeddu Journal: J Urol Date: 2012-04-11 Impact factor: 7.450
Authors: Karim Touijer; Didier Jacqmin; Louis R Kavoussi; Francesco Montorsi; Jean Jacques Patard; Craig G Rogers; Paul Russo; Robert G Uzzo; Hendrik Van Poppel Journal: Eur Urol Date: 2009-10-20 Impact factor: 20.096
Authors: Kirsten L Simmons; Jason C Chandrapal; Steven Wolf; Henry E Rice; Elisabeth E Tracy; Tamara Fitzgerald; Gina-Maria Pomann; Jonathan C Routh Journal: J Pediatr Urol Date: 2021-03-19 Impact factor: 1.921